SCHEDULE 13G

Company

abrdn Life Sciences Investors

Filed

January 28, 2019

Accession Number

0001445546-19-000483

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →